CYTK · Cytokinetics Inc
$74.13
+0.68 (+0.93%)
At close · Aug 14
Market Cap
$10.31B
Shares
139.02M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding CYTK
510 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Capital Appreciation Fund | — | 5,105,689 | $336,515,962 | 0.51% | Long | 2026-03-31 | |
| iShares Core S&P Mid-Cap ETF | — | 4,048,023 | $266,805,196 | 0.25% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 3,902,739 | $257,229,527 | 0.01% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE FUND | — | 3,482,614 | $222,782,818 | 0.60% | Long | 2026-04-30 | |
| iShares Russell 2000 ETF | — | 2,923,781 | $192,706,406 | 0.27% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 2,839,773 | $187,169,438 | 0.11% | Long | 2026-03-31 | |
| Fidelity OTC Portfolio | — | 2,271,300 | $145,295,061 | 0.36% | Long | 2026-04-30 | |
| SMALLCAP World Fund Inc | — | 2,114,898 | $139,392,927 | 0.17% | Long | 2026-03-31 | |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | — | 1,686,600 | $111,163,806 | 0.49% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | — | 1,590,770 | $104,847,651 | 0.27% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 1,365,835 | $90,022,185 | 0.11% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 1,331,453 | $87,756,067 | 1.18% | Long | 2026-03-31 | |
| T. Rowe Price Small-Cap Value Fund, Inc. | — | 1,178,125 | $77,650,219 | 0.84% | Long | 2026-03-31 | |
| Fidelity Small Cap Index Fund | — | 1,183,484 | $75,707,471 | 0.23% | Long | 2026-04-30 | |
| JNL/T. Rowe Price Capital Appreciation Fund | — | 1,100,581 | $72,539,294 | 0.52% | Long | 2026-03-31 | |
| T. Rowe Price Small-Cap Stock Fund, Inc. | — | 1,072,574 | $70,693,352 | 0.88% | Long | 2026-03-31 | |
| T. Rowe Price Capital Appreciation Equity ETF | — | 1,045,102 | $68,882,673 | 1.11% | Long | 2026-03-31 | |
| State Street SPDR S&P MidCap 400SM ETF Trust | MDY | 921,542 | $60,738,833 | 0.25% | Long | 2026-03-31 | |
| iShares Russell 2000 Value ETF | — | 912,972 | $60,173,985 | 0.48% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 896,972 | $59,119,425 | 0.73% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 677,623 | $52,014,341 | 0.12% | Long | 2026-05-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 664,979 | $51,043,788 | 0.29% | Long | 2026-05-31 | |
| Schwab U.S. Small-Cap ETF | — | 635,330 | $48,767,931 | 0.21% | Long | 2026-05-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 575,188 | $44,151,431 | 0.75% | Long | 2026-05-29 | |
| VANGUARD EXPLORER FUND | — | 684,813 | $43,807,488 | 0.20% | Long | 2026-04-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 663,136 | $43,707,294 | 0.40% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | — | 597,189 | $39,360,727 | 0.25% | Long | 2026-03-31 | |
| T. Rowe Price Institutional Small-Cap Stock Fund | — | 586,266 | $38,640,792 | 0.89% | Long | 2026-03-31 | |
| Fidelity Small Cap Growth Fund | — | 561,677 | $35,930,478 | 0.43% | Long | 2026-04-30 | |
| Select Biotechnology Portfolio | — | 449,175 | $34,478,673 | 0.65% | Long | 2026-05-31 | |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO | — | 510,356 | $33,637,564 | 0.51% | Long | 2026-03-31 | |
| Fidelity Stock Selector Small Cap Fund | — | 502,775 | $32,162,517 | 0.46% | Long | 2026-04-30 | |
| Eventide Healthcare & Life Sciences Fund | — | 479,028 | $31,572,735 | 1.99% | Long | 2026-03-31 | |
| Schwab U.S. Mid-Cap ETF | — | 356,940 | $27,398,714 | 0.19% | Long | 2026-05-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 349,860 | $26,855,254 | 0.14% | Long | 2026-05-31 | |
| iShares S&P Mid-Cap 400 Growth ETF | — | 400,888 | $26,422,528 | 0.27% | Long | 2026-03-31 | |
| Federated Hermes Kaufmann Fund | — | 400,000 | $25,588,000 | 0.55% | Long | 2026-04-30 | |
| Fidelity Puritan Fund | — | 329,900 | $25,323,124 | 0.07% | Long | 2026-05-31 | |
| Penn Series Flexibly Managed Fund | — | 382,314 | $25,198,316 | 0.54% | Long | 2026-03-31 | |
| Strategic Advisers U.S. Total Stock Fund | — | 305,111 | $23,420,320 | 0.02% | Long | 2026-05-31 | |
| Fidelity Series Small Cap Opportunities Fund | — | 353,776 | $22,631,051 | 0.45% | Long | 2026-04-30 | |
| Fidelity Advisor Equity Growth Fund | — | 291,801 | $22,398,645 | 0.17% | Long | 2026-05-31 | |
| SmallCap Fund | — | 349,900 | $22,383,103 | 1.06% | Long | 2026-04-30 | |
| Small Cap Growth Fund | — | 334,272 | $21,383,380 | 0.42% | Long | 2026-04-30 | |
| JNL/T. Rowe Price Mid-Cap Growth Fund | — | 319,300 | $21,045,063 | 0.52% | Long | 2026-03-31 | |
| VIP Mid Cap Portfolio | — | 307,200 | $20,247,552 | 0.25% | Long | 2026-03-31 | |
| Fidelity Advisor Biotechnology Fund | — | 312,871 | $20,014,358 | 1.05% | Long | 2026-04-30 | |
| Fidelity Total Market Index Fund | — | 249,622 | $19,160,985 | 0.01% | Long | 2026-05-31 | |
| iShares S&P Mid-Cap 400 Value ETF | — | 285,745 | $18,833,453 | 0.24% | Long | 2026-03-31 | |
| Fidelity Small Cap Growth K6 Fund | — | 281,164 | $17,986,061 | 0.42% | Long | 2026-04-30 |
Showing 1–50 of 510 positions
Key facts
CIK
1061983
CUSIP
23282W605
13F (30d)
455 filings
453 filers
Visit website
Investor relations